Finance

Lists
NAN:ASX
Nanosonics Ltd.
2,81 AUD
-1,40%
(-0,040) 1D
13 ოქტ, 16:10:28 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NAN...
Open
2,81 AUD
High
2,87 AUD
Low
2,81 AUD
Mkt. cap
840,66 მლნ.
Avg. vol.
1,10 მლნ.
Volume
1,37 მლნ.
P/E ratio
48,67
52-wk high
4,76 AUD
52-wk low
2,64 AUD
EPS
0,06 AUD
Shares outstanding
299,17 მლნ.
No. of employees
508
Open
2,81 AUD
High
2,87 AUD
Low
2,81 AUD
Mkt. cap
840,66 მლნ.
Avg. vol.
1,10 მლნ.
Volume
1,37 მლნ.
P/E ratio
48,67
52-wk high
4,76 AUD
52-wk low
2,64 AUD
EPS
0,06 AUD
Shares outstanding
299,17 მლნ.
No. of employees
508
News stories
From web sources and news partners
Profile
Nanosonics is an ASX-listed company in the healthcare industry which manufactures and distributes ultrasound probe disinfectors and other related technologies. It has offices in Australia, the U.S. and Canada, the United Kingdom and Europe, employing more than 300 people. The company's Trophon is the product used to reduce the spread of Healthcare Acquired Infections. Its Trophon2 product includes AcuTrace technology, which enables digital record keeping and provides workflows for ultrasound probe high level disinfection. Wikipedia
About Nanosonics Ltd.
CEOმაიკლ კავანაღ
Employees508
Founded2001
Headquartersსიდნეი, ახალი სამხრეთი უელსი, ავსტრალია
SectorMedical device
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
51,12 მლნ.
51,12 მლნ.
50,83 მლნ.
50,83 მლნ.
Cost of goods sold
12,11 მლნ.
12,11 მლნ.
11,43 მლნ.
11,43 მლნ.
Cost of revenue
12,11 მლნ.
12,11 მლნ.
11,43 მლნ.
11,43 მლნ.
Research and development expenses
7,70 მლნ.
7,70 მლნ.
8,19 მლნ.
8,19 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27,06 მლნ.
27,06 მლნ.
27,74 მლნ.
27,74 მლნ.
Operating expense
34,44 მლნ.
34,44 მლნ.
35,50 მლნ.
35,50 მლნ.
Total operating expenses
46,56 მლნ.
46,56 მლნ.
46,93 მლნ.
46,93 მლნ.
Operating income
4,56 მლნ.
4,56 მლნ.
3,90 მლნ.
3,90 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
5,31 მლნ.
5,31 მლნ.
4,74 მლნ.
4,74 მლნ.
EBT excluding unusual items
5,31 მლნ.
5,31 მლნ.
4,76 მლნ.
4,76 მლნ.
Income tax expense
489,50 ათ.
489,50 ათ.
649,00 ათ.
649,00 ათ.
Effective tax rate
9,22%
9,22%
13,68%
13,68%
Other operating expenses
-323,50 ათ.
-323,50 ათ.
-426,00 ათ.
-426,00 ათ.
Net income
4,82 მლნ.
4,82 მლნ.
4,10 მლნ.
4,10 მლნ.
Net profit margin
9,43%
9,43%
8,06%
8,06%
Earnings per share
-
-
-
-
Interest and investment income
1,47 მლნ.
1,47 მლნ.
1,43 მლნ.
1,43 მლნ.
Interest expense
-350,00 ათ.
-350,00 ათ.
-490,50 ათ.
-490,50 ათ.
Net interest expenses
1,12 მლნ.
1,12 მლნ.
938,00 ათ.
938,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
5,82 მლნ.
5,82 მლნ.
5,24 მლნ.
5,24 მლნ.
Gain or loss from assets sale
-
-
16,50 ათ.
16,50 ათ.
AI content may include mistakes. Learn more
Google აპები